It was seen through different databases that HMMR was highly upregulated in various malignancies, including breast cancer, and HMMR has a correlation with AURKA, TPX2, and CDK1, which are also involved in the upregulation of mTOR signaling pathways. This evidence concerns the gene TPX2 and breast carcinoma.